GS-6779
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for GS-6779, covering 2026-01-23 to 2026-01-23. Get the full timeline:
Most recent: Clinical Trial Update: Study of HBV Therapeutic Vaccines GS-2829 and GS-6779 in Healthy Participants and Participants With Chronic Hepatitis B [Phase 1]